Patent · US Active

Pyrrolo[2,3-D]pyrimidine compounds

US8987283B2 · kind B2 · utility

3Cited by
33References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 30, 2012
Grant dateMar 24, 2015
Priority date—
Expiry dateDec 12, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein is pyrrolo{2,3-d}pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing this compounds, and methods for the preparation of these compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.